As atopic dermatitis (AD) prevalence has increased in children over several decades, it's critical for physicians to recognize the environmental and demographic factors contributing to the change.
Panelists review the traditional pharmacologic treatment options for asthma and the challenges with them
Defining the recommended guidelines and the formulary restrictions with the standard of care for asthma.
September 19th 2021, 3:46pm
Michael E. Wechsler, MD, a pulmonologist at National Jewish Health, details the ways that the treatment of eosinophilic asthma differs from other forms of asthma.
September 12th 2021, 2:00pm
Michael E. Wechsler, MD, a pulmonologist at National Jewish Health, discusses the conditions that can develop as a result of abnormal eosinophilic activity.
September 5th 2021, 1:40pm
Using the argument that regularly taking medication is a great way to earn parents' trust is a great tactic to encourage children and teenagers to remain adherent to their asthma therapies, said William "Andy" Nish, MD, an allergist and immunologist in Georgia.
September 3rd 2021, 5:30pm
It is the third set of warnings for certain Janus kinase (JAK) inhibitors due to the risk of heart attack or stroke, cancer, blood clots, and death.
August 29th 2021, 2:00pm
Switching patients with asthma to a biologic medication purely because that patient is not adherent to inhaled medications gets in the way of a physician's goal of being good stewards of patient care and finances, said William "Andy" Nish, MD.
August 25th 2021, 5:30pm
Randomized controlled trials on asthma hospitalization prevention are limited, but patient and caregiver education should be a top priority, investigators said.
August 22nd 2021, 12:00pm
There are several biomarkers that act as therapeutic targets for asthma, and plenty of medications aimed at inhibiting them, according to William "Andy" Nish, MD.
August 19th 2021, 10:00pm
A review of therapies for atopic dermatitis (AD) found adequate net health benefit for new treatments. However, safety remains a concern for the Janus kinase (JAK) inhibitors.
August 16th 2021, 5:30pm
Most patients said they had received instruction on how to use their inhalers from a pharmacist or physician, but only 21% said they had received instruction from both.
August 13th 2021, 5:00pm
Nearly 9 in 10 children given intravenous (IV) magnesium for refractory asthma ended up being admitted to the hospital, but new research suggests that may be partly due to a lack of clarity about the therapy’s safety profile.
.JPG?w=200&fit=crop&auto=format)